Abstract:BACKGROUND & OBJECTIVE:Several researches have reported that epidermal growth factor receptor (EGFR) is expressed frequently in hepatocellular carcinoma (HCC) and paratumor tissues, most likely to contribute to the biological characteristics of HCC, including invasion, metastasis, and resistance to chemotherapy and radiotherapy. The single agent of cetuximab and erlotinib can inhibit the proliferation of HCC cells in vivo and in vitro. This study was to investigate the effects of cetuximab combined erlotinib on the proliferation of HCC cells, and explore the molecular mechanism.METHODS:Increasing concentrations of cetuximab (5-500 mg/mL) and erlotinib (2.5-250 micromol/L) alone or in combination were administrated to HCC cell lines HepG2 and Bel-7402. The inhibitory effects of the drugs on cell proliferation at different time points were observed; the combination index (CI) of these two agents was calculated. The expression of key enzymes in EGFR signaling transduction pathway in HepG2 and Bel-7402 cells after different treatments was detected by Western blot.RESULTS:The single agent of cetuximab and erlotinib inhibited the proliferation of HCC cells in a time-and dose-dependent manner; after 72-hour treatment, the proliferation inhibition rates of HepG2 cells were (43.1+/-1.9)% and (83.4+/-1.3)%, and those of Bel-7402 cells were (35.1+/-2.6)% and (73.9+/-1.2)%. With maximal inhibitory effects of cetuximab combined erlotinib, the proliferation inhibition rates of HepG2 and Bel-7402 cells were (91.1+/-1.0)% and (84.6+/-1.1)%, respectively. The CIs of different concentrations of these two agents at different time points were all less than 1, suggested that they have obvious synergistic activity. The expression of activated key enzymes (p-EGFR, p-ERK1/2, p-AKT) in EGFR signaling transduction pathway in HepG2 and Bel-7402 cells were down-regulated more obviously when these two agents were administrated in combination.CONCLUSIONS:The single agent of cetuximab and erlotinib can inhibit the proliferation of HepG2 and Bel-7402 cells through down-regulating activated key enzymes in EGFR signaling transduction pathway, and they have obvious synergistic activity. The combined EGFR-targeting therapy on HCC xenografts in vivo and on HCC patients is worth of further exploration.

Inhibition Effect of Eriocalyxin B Against Angiogenesis of Hepatocelluar Carcinoma and Human Normal Endothelial Cell

Eriocalyxin B induces apoptosis in hepatocellular carcinoma (HCC) cells

Inhibitory effects of icaritin on proliferation of three human carcinoma cell lines

Inhibitory Effect of EGFR Antisense Oligodeoxynucleotide on Human Hepatoma Cell Line.

Erianin suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK MAPK signaling pathways.

Inhibitory Effect of Cucurbitacin E on the Proliferation of Breast Cancer Cells and Its Mechanism

Hepatocellular Carcinoma Growth is Inhibited Byeuphorbia Helioscopial. Extract in Nude Mice Xenografts

Impact of ER520, a Candidate of Selective Estrogen Receptor Modulators, on in Vitro Cell Growth, Migration, Invasion, Angiogenesis and in Vivo Tumor Xenograft of Human Breast Cancer Cells

Biological and anti-vascular activity evaluation of ethoxy-erianin phosphate as a vascular disrupting agent.

Erianin inhibits the oncogenic properties of hepatocellular carcinoma via inducing DNA damage and aberrant mitosis

Effects of Endothelial Cells Conditioned Medium on the Proliferation and Invasion of Hepatocellular Carcinoma Cells

Inhibitory Effect of EGCG on Proliferation and HIF-1α/VEGF Expression in Cell Line HepG2

The Anti-Carcinogenesis Properties Of Erianin In The Modulation Of Oxidative Stress-Mediated Apoptosis And Immune Response In Liver Cancer

The Effect of Icariin on Human Hepatoellular Carcinomas Cell Apoptosis and Cell Cycle Arrest

Inhibitory Effect of Serum Containing Eupolyphaga on the Proliferation of Human Hepatoma Cell Line HepG-2

Effects of angiopoietin 2 single-chain antibody on human hepatocellular carcinoma in nude mice

[Influence of Tumor Microenvironment of Hepatocellular Carcinoma on the Proliferation of Vascular Endothelial Cells and Vascular Angiogenesis Ability].

The Effect of Bortezomib on Migration of Endothelial Cells and Angiogenesis

Experimental study of extract of fungi of huaier on angiogenesis in vitro

Inhibitory Effect of Antisense Vascular Endothelial Growth Factor 165 Eukaryotic Expression Vector on Proliferation of Hepatocellular Carcinoma Cells

[Effects of Cetuximab Combined Erlotinib on Proliferation of Human Hepatocellular Carcinoma Cell Lines HepG2 and Bel-7402].